Table 1.
Characteristic | Lp(a) <50 mg/dL (n=5359) | Lp(a) ≥50 mg/dL (n=1346) | p-value† |
---|---|---|---|
Age | 62.0 (10.3) | 62.4 (10.0) | 0.27 |
Male, % | 2614 (48.8%) | 550 (40.9%) | <0.001 |
Race, % | |||
White | 2169 (40.5%) | 413 (30.7%) | <0.001 |
Chinese | 718 (13.4%) | 75 (5.6%) | |
African-American | 1207 (22.5%) | 641 (47.6%) | |
Hispanic | 1265 (23.6%) | 217 (16.1%) | |
Education, % | |||
High school or less | 1946 | 482 | 0.65 |
Some college | 1503 | 394 | |
College or more | 1893 | 464 | |
Body mass index, kg/m2 | 28.2 (5.4) | 28.8 (5.7) | <0.001 |
Family history of MI, | 2106 (41.8%) | 583 (46.3%) | 0.004 |
Hypertension, % | 2328 (43.4%) | 670 (49.8%) | <0.001 |
Systolic blood pressure, mmHg | 126.0 (21.3) | 128.2 (22.1) | 0.001 |
Diastolic blood pressure, mmHg | 71.7 (10.2) | 72.4 (10.4) | 0.023 |
Total cholesterol, mg/dL | 191.7 (35.1) | 203.1 (36.6) | <0.001 |
HDL cholesterol, mg/dL | 114.8 (30.8) | 126.1 (32.1) | <0.001 |
Glucose, mg/dL | 97.5 (30.4) | 96.6 (29.4) | 0.32 |
Diabetes, % | 649 (12.1%) | 193 (14.4%) | 0.007 |
Smoking status, % | |||
Never | 2688 (50.3%) | 675 (50.4%) | 0.17 |
Former | 1980 (37.1%) | 472 (35.2%) | |
Current | 675 (12.6%) | 193 (14.4%) | |
hs-CRP, mg/dL | 3.7 (5.8) | 4.2 (6.4) | 0.008 |
eGFR | 81.3 (18.5) | 80.7 (18.3) | 0.22 |
Anti-hypertensive use, % | 1927 (36.0%) | 560 (41.6%) | <0.001 |
Statin use, % | 1078 (18.9%) | 267 (27.0%) | <0.001 |
Aspirin use, % | 1669 (31.2%) | 449 (33.4%) | 0.12 |
Coronary artery calcium score | 140.9 (394.4) | 164.8 (499.7) | 0.060 |
Mitral annular calcium score | 48.8 (438.0) | 48.7 (386.7) | 1.00 |
Thoracic aortic calcium score | 220.3 (871.5) | 204.2 (836.3) | 0.54 |
MI=myocardial infarction; HDL=high-density lipoprotein
Continuous variables are expressed as mean (SD). Categorical variables are N (percent).
Comparisons were made between Lp(a)<50 mg/dL and Lp(a) ≥50 mg/dL. Fisher’s exact used to make statistical comparison.